Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Lineage Cell Therapeutics, Inc. announced that the company has received a grant from the California Institute for Regenerative Medicine, to support the 1st Annual Spinal Cord Injury Investor Symposium, a newly created forum to discuss the recent innovation, advancements, and challenges in the treatment of spinal cord injury.